文献速递骨肌技术与安全PETCT

68Ga-FAPI PET/CT在前瞻性类风湿关节炎研究中的表现

68Ga-FAPI PET/CT for Rheumatoid Arthritis: A Prospective Study.
PubMed 文献 · Radiology · 2023-02-28

这项前瞻性研究纳入20例类风湿关节炎患者,比较68Ga-FAPI与18F-FDG PET/CT评估关节疾病活动性的能力。结果显示68Ga-FAPI PET/CT检测到的受累关节数量更多,且与临床和实验室活动性指标及影像学关节破坏进展相关。

要点

  • 68Ga-FAPI PET/CT可检测到所有被两种PET/CT共同识别的244个受累关节。
  • 68Ga-FAPI PET/CT较18F-FDG PET/CT多检出15个(6.1%)FAPI高摄取关节。
  • 68Ga-FAPI PET/CT的关节摄取程度及受累范围与疾病活动性指标相关。

关键影像表现/征象

  • 两种PET/CT技术联合输出帮助检测到244个受累关节,所有关节在68Ga-FAPI PET/CT上均显示阳性结果。
  • 6例(30%)参与者的15个(6.1%)FAPI高摄取关节在18F-FDG PET/CT上未被检测到。
  • 每位参与者最受累关节的最大标准化摄取值在68Ga-FAPI PET/CT上高于18F-FDG PET/CT(9.54±4.92 vs 5.85±2.81,P=.001)。

诊断标准与关键数值

  • 68Ga-FAPI和18F-FDG PET/CT的关节最大标准化摄取值均与实验室C反应蛋白水平正相关(r=0.49,P=.03和r=0.54,P=.01)。
  • 68Ga-FAPI PET/CT的PET关节计数和PET关节指数评分与大多数临床疾病活动性变量及关节损伤的影像学进展正相关(P<.05)。

临床应用与阅片要点

  • 68Ga-FAPI PET/CT可检出18F-FDG PET/CT未显示的类风湿关节炎受累关节,阅片时需注意FAPI高摄取关节。
  • 68Ga-FAPI PET/CT的关节摄取程度和范围与疾病活动性相关,可用于评估关节受累程度。

局限性

  • 样本量较小(20例参与者),可能影响结果的普遍性。
  • 单中心前瞻性研究,需更大规模多中心研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background In rheumatoid arthritis (RA), fibroblast-like synoviocyte cells, which are involved in inflammation of the articular cartilage and bone, overexpress fibroblast activation protein (FAP). This is a feature that could be leveraged to improve imaging assessment of disease. Purpose To determine the performance of gallium 68 (68Ga)-labeled FAP inhibitor (FAPI) in assessing joint disease activity of RA and to compare with fluorine 18 (18F) fluorodeoxyglucose (FDG) imaging. Materials and Methods Twenty participants with RA (15 women; mean age, 55 years ± 10 [SD]) were prospectively enrolled from September 2020 to December 2021 and underwent clinical and laboratory assessment of disease activity and dual-tracer PET/CT (68Ga-FAPI and 18F-FDG) imaging. Imaging-derived variables of PET joint count (the number of joints positive for RA at PET) and PET articular index (a sum of the points of the joints using a three-point scale) were correlated to clinical and laboratory variables of disease activity. Results The combined output of both PET/CT techniques helped detect 244 affected joints, all of which showed positive results at 68Ga-FAPI PET/CT. However, fifteen of 244 (6.1%) FAPI-avid joints in six of 20 (30%) participants were not detected at 18F-FDG PET/CT. The maximum standardized uptake value of the most affected joint in each participant was higher in 68Ga-FAPI than in 18F-FDG PET/CT (9.54 ± 4.92 vs 5.85 ± 2.81, respectively; P = .001). The maximum standardized uptake values of the joints at both 68Ga-FAPI and 18F-FDG PET/CT were positively correlated with laboratory evaluation of C-reactive protein levels (r = 0.49 [P = .03] and 0.54 [P = .01], respectively). The PET joint count and PET articular index scores at 68Ga-FAPI PET/CT were also positively correlated with most clinical disease activity variables and radiographic progression of joint damage (P < .05). Conclusion In participants with rheumatoid arthritis who underwent gallium 68 fibroblast activation protein inhibitor PET/CT, the extent of joint involvement correlated with clinical and laboratory variables of disease activity and showed a greater amount and degree of affected joints than at fluorine 18 fluorodeoxyglucose PET/CT. Clinical trial registration no. NCT04514614 © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Williams and Ahlman in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Luo, Pan, Zhou, et al. 68Ga-FAPI PET/CT for Rheumatoid Arthritis: A Prospective Study. Radiology. 2023. PMID: 36853178. doi:10.1148/radiol.222052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。